Literature DB >> 2727466

Surrogate endpoints in clinical trials: ophthalmologic disorders.

A Hillis1, D Seigel.   

Abstract

We examined three examples of surrogate observations in ophthalmology. The first represents a simple case: the status of one eye is used as a surrogate for the (unobservable) status of the opposite eye in the same individual. The second and third examples represent possible extrapolation of long term results on the basis of early changes. These examples are used to illustrate the assumptions intrinsic in the use of surrogate variables.

Entities:  

Mesh:

Year:  1989        PMID: 2727466     DOI: 10.1002/sim.4780080406

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  6 in total

Review 1.  Surrogate endpoints: a basis for a rational approach.

Authors:  J P Boissel; J P Collet; P Moleur; M Haugh
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Surrogate end points in clinical trials.

Authors:  S S Ellenberg
Journal:  BMJ       Date:  1991-01-12

Review 3.  Surrogate endpoints in Parkinson's disease research.

Authors:  Kevin M Biglan; Robert G Holloway
Journal:  Curr Neurol Neurosci Rep       Date:  2003-07       Impact factor: 5.081

Review 4.  Meta-analysis for the evaluation of surrogate endpoints in cancer clinical trials.

Authors:  Qian Shi; Daniel J Sargent
Journal:  Int J Clin Oncol       Date:  2009-04-24       Impact factor: 3.402

5.  Measuring Surrogacy in Clinical Research: With an application to studying surrogate markers for HIV Treatment-as-Prevention.

Authors:  Rui Zhuang; Ying Qing Chen
Journal:  Stat Biosci       Date:  2019-06-04

6.  Accounting for treatment by center interaction in sample size determinations and the use of surrogate outcomes in the pessary for the prevention of preterm birth trial: a simulation study.

Authors:  Andrew R Willan
Journal:  Trials       Date:  2016-07-05       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.